Beta-adrenergic blockade and vasospasm.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011928:Raynaud Disease / Q000139:chemically induced*; D014661:Vasoconstriction / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D008790:Metoprolol